Acyl-CoA synthetase

From WikiMD's Medical Encyclopedia

Revision as of 19:26, 27 March 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Acyl-CoA synthetase is an enzyme that plays a crucial role in the metabolism of fatty acids within biological cells. It catalyzes the activation of fatty acids in a two-step process, which is essential for their subsequent degradation through beta-oxidation or incorporation into lipids. This enzyme is pivotal in the biochemistry of lipid metabolism and energy production.

Function

Acyl-CoA synthetase activates fatty acids by converting them into their Coenzyme A (CoA) derivatives, a process necessary for the fatty acids to undergo further metabolic pathways. The activation occurs in two steps:

  1. The fatty acid reacts with ATP to form an acyl-adenylate and pyrophosphate (PPi).
  2. The acyl-adenylate then reacts with CoA to form acyl-CoA and AMP.

This reaction is crucial because the acyl-CoA product is a substrate for several important metabolic pathways, including beta-oxidation, which generates ATP, and the synthesis of complex lipids such as phospholipids, cholesterol esters, and triglycerides.

Isoforms

There are multiple isoforms of acyl-CoA synthetase, each with specificity for different chain lengths of fatty acids. These include:

  • Very long-chain acyl-CoA synthetase (ACSVL), which activates fatty acids with chains longer than 22 carbons.
  • Long-chain acyl-CoA synthetase (ACSL), which targets fatty acids with chains between 12 to 20 carbons.
  • Medium-chain acyl-CoA synthetase (ACSM), specific for fatty acids with chains of 4 to 12 carbons.
  • Short-chain acyl-CoA synthetase (ACSS), which acts on fatty acids with fewer than 6 carbon atoms.

The existence of different isoforms allows cells to process a wide range of fatty acids, reflecting the diversity of lipid species in nature and their various roles in cell structure and signaling.

Clinical Significance

Mutations or dysregulation in the genes encoding acyl-CoA synthetases can lead to metabolic disorders. For example, defects in the long-chain acyl-CoA synthetase can result in nonketotic hypoglycemia and fatty liver, highlighting the enzyme's importance in energy metabolism and lipid storage. Furthermore, the role of acyl-CoA synthetase in lipid synthesis and remodeling makes it a potential target for therapeutic intervention in metabolic diseases, such as diabetes mellitus and obesity, as well as in cardiovascular diseases.

See Also

Stub icon
   This article is a biochemistry stub. You can help WikiMD by expanding it!



Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes


Ad. Transform your life with W8MD's

GLP-1 weight loss injections special from $29.99 with insurance

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.